Literature DB >> 28283760

Single-blind, randomized, pilot study combining shiatsu and amitriptyline in refractory primary headaches.

Veronica Villani1, Luca Prosperini2, Fulvio Palombini3, Francesco Orzi4, Giuliano Sette4.   

Abstract

Complementary alternative medicine, such as shiatsu, can represent a suitable treatment for primary headaches. However, evidence-based data about the effect of combining shiatsu and pharmacological treatments are still not available. Therefore, we tested the efficacy and safety of combining shiatsu and amitriptyline to treat refractory primary headaches in a single-blind, randomized, pilot study. Subjects with a diagnosis of primary headache and who experienced lack of response to ≥2 different prophylactic drugs were randomized in a 1:1:1 ratio to receive shiatsu plus amitriptyline, shiatsu alone, or amitriptyline alone for 3 months. Primary endpoint was the proportion of patients experiencing ≥50%-reduction in headache days. Secondary endpoints were days with headache per month, visual analogue scale, and number of pain killers taken per month. After randomization, 37 subjects were allocated to shiatsu plus amitriptyline (n = 11), shiatsu alone (n = 13), and amitriptyline alone (n = 13). Randomization ensured well-balanced demographic and clinical characteristics at baseline. Although all the three groups improved in terms of headache frequency, visual analogue scale score, and number of pain killers (p < 0.05), there was no between-group difference in primary endpoint (p = ns). Shiatsu (alone or in combination) was superior to amitriptyline in reducing the number of pain killers taken per month (p < 0.05). Seven (19%) subjects reported adverse events, all attributable to amitriptyline, while no side effects were related with shiatsu treatment. Shiatsu is a safe and potentially useful alternative approach for refractory headache. However, there is no evidence of an additive or synergistic effect of combining shiatsu and amitriptyline. These findings are only preliminary and should be interpreted cautiously due to the small sample size of the population included in our study. Trial registration 81/2010 (Ethical Committee, S. Andrea Hospital, Sapienza University, Rome, Italy).

Entities:  

Keywords:  Amitriptyline; Complementary alternative medicine; Migraine; Primary headache; Shiatsu

Mesh:

Substances:

Year:  2017        PMID: 28283760     DOI: 10.1007/s10072-017-2888-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  34 in total

Review 1.  Emerging behavioral treatments for migraine.

Authors:  Todd A Smitherman; Rebecca E Wells; Sutapa G Ford
Journal:  Curr Pain Headache Rep       Date:  2015-04

Review 2.  Migraine: multiple processes, complex pathophysiology.

Authors:  Rami Burstein; Rodrigo Noseda; David Borsook
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

Review 3.  CAM in the real world: you may practice evidence-based medicine, but your patients don't.

Authors:  Robert P Cowan
Journal:  Headache       Date:  2014-04-25       Impact factor: 5.887

Review 4.  Medication overuse and chronic migraine: a critical review according to clinical pharmacology.

Authors:  Anna Ferrari; Carlo Baraldi; Emilio Sternieri
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-05-31       Impact factor: 4.481

5.  [Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].

Authors:  Manuel Gracia-Naya; Sonia Santos-Lasaosa; Consuelo Ríos-Gómez; Sara Sánchez-Valiente; M José García-Gomara; Ana M Latorre-Jiménez; Jorge Artal-Roy; José A Mauri-Llerda
Journal:  Rev Neurol       Date:  2011-08-16       Impact factor: 0.870

Review 6.  Efficacy of biofeedback for migraine: a meta-analysis.

Authors:  Yvonne Nestoriuc; Alexandra Martin
Journal:  Pain       Date:  2006-11-02       Impact factor: 6.961

7.  Migraine chronification.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

8.  Effect of acupressure and trigger points in treating headache: a randomized controlled trial.

Authors:  Lisa Li-Chen Hsieh; Horng-Huei Liou; Liang-Huei Lee; Tony Hsiu-Hsi Chen; Amy Ming-Fang Yen
Journal:  Am J Chin Med       Date:  2010       Impact factor: 4.667

9.  Adherence to oral migraine-preventive medications among patients with chronic migraine.

Authors:  Zsolt Hepp; David W Dodick; Sepideh F Varon; Patrick Gillard; Ryan N Hansen; Emily B Devine
Journal:  Cephalalgia       Date:  2014-08-27       Impact factor: 6.292

10.  Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.

Authors:  Paolo Martelletti; Zaza Katsarava; Christian Lampl; Delphine Magis; Lars Bendtsen; Andrea Negro; Michael Bjørn Russell; Dimos-Dimitrios D Mitsikostas; Rigmor Højland Jensen
Journal:  J Headache Pain       Date:  2014-08-28       Impact factor: 7.277

View more
  3 in total

Review 1.  Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.

Authors:  Amr Menshawy; Hussien Ahmed; Ammar Ismail; Abdelrahman Ibrahim Abushouk; Esraa Ghanem; Ravikishore Pallanti; Ahmed Negida
Journal:  Neurol Sci       Date:  2017-09-23       Impact factor: 3.307

2.  Analysis of the analgesic effects of tricyclic antidepressants on neuropathic pain, diabetic neuropathic pain, and fibromyalgia in rat models.

Authors:  Zhenlong Qin; Lei Wang; Guoyan Li; Xuwen Qian; Jie Zhang; Ying Guo; Guokai Liu
Journal:  Saudi J Biol Sci       Date:  2020-06-01       Impact factor: 4.219

3.  The Experience of Shiatsu for Care Partners and Persons Living With Dementia: a Qualitative Pilot Study.

Authors:  Leisa Bellmore
Journal:  Int J Ther Massage Bodywork       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.